Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intraarterial lidocaine for pain after uterine fibroid embolization
IRCT20220126053835N1Phase 3Completed
- Sponsor
- Isfahan University of Medical Sciences
- Start
- Jul 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of lidocaine in pain (2 arms), sponsored by Isfahan University of Medical Sciences. Primary endpoints: Postoperative pain and Pethidine dose. Started Jul 2022; status: completed.
02
Drugs
lidocaine
03
Conditions
pain
Beyond the preview
Go deeper on IRCT20220126053835N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20220126053835N1.